Cargando…
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
OBJECTIVES: In 2002, the UK's National Institute for Health and Care Excellence concluded that the multiple sclerosis (MS) disease modifying therapies; interferon-β and glatiramer acetate, were not cost effective over the short term but recognised that reducing disability over the longer term m...
Autores principales: | Palace, Jacqueline, Bregenzer, Thomas, Tremlett, Helen, Oger, Joel, Zhu, Fheng, Boggild, Mike, Duddy, Martin, Dobson, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902459/ https://www.ncbi.nlm.nih.gov/pubmed/24441054 http://dx.doi.org/10.1136/bmjopen-2013-004073 |
Ejemplares similares
-
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
por: Palace, Jacqueline, et al.
Publicado: (2019) -
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
por: Boggild, Mike, et al.
Publicado: (2009) -
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future
por: Pickin, Mark, et al.
Publicado: (2009) -
The Multiple Sclerosis Prodrome: Evidence to Action
por: Tremlett, Helen, et al.
Publicado: (2022) -
Stroke Lesion Segmentation in FLAIR MRI Datasets Using Customized Markov Random Fields
por: Subbanna, Nagesh K., et al.
Publicado: (2019)